1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders
US-2015353510-A1 · Dec 10, 2015 · US
High-performing metal-free primary explosive
US11858902B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11858902-B2 |
| Application number | US-202117221866-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 5, 2021 |
| Priority date | Jun 12, 2020 |
| Publication date | Jan 2, 2024 |
| Grant date | Jan 2, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure relates to a novel compound suitable for a metal-free primary explosive, and the method of making and using the novel compound. The novel compound can undergo a deflagration to detonation transition (DDT) to initiate detonation of a larger body of secondary explosive. The compound has a structure of Formula I:
First claim
Opening claim text (preview).
We claim: 1. A compound of Formula I: or a stereoisomer thereof. 2. A composition, wherein the composition comprises the compound of claim 1 . 3. A method of using the compound of claim 1 , which method comprises deflagrating the compound to detonation transition (DDT) to initiate detonation of a larger body of secondary explosive.
Assignees
Inventors
Classifications
- C07D249/04Primary
1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles · CPC title
Compositions containing a nitrated organic compound · CPC title
Non-electric detonators; Blasting caps; Primers · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11858902B2 cover?
- The present disclosure relates to a novel compound suitable for a metal-free primary explosive, and the method of making and using the novel compound. The novel compound can undergo a deflagration to detonation transition (DDT) to initiate detonation of a larger body of secondary explosive. The compound has a structure of Formula I:
- Who is the assignee on this patent?
- Purdue Research Foundation
- What technology area does this patent fall under?
- Primary CPC classification C07D249/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).